600518 Kangmei Pharmaceutical
- 2.27
- +0.09+4.13%
Kangmei Pharmaceutical News
Announcement on abnormal fluctuations in Kangmei Pharmaceutical\'s stock trading
Reply to the inquiry letter on abnormal fluctuations in Kangmei Pharmaceutical\'s stock trading
Kangmei Pharmaceutical\'s announcement on holding a performance briefing for the third quarter of 2024
Kangmei Pharmaceutical: Announcement of Resolutions of the Fourth Interim Meeting of the 9th Board of Directors of Kangmei Pharmaceutical in 2024
Kangmei Pharmaceutical: Announcement of Resolutions of the Third Interim Meeting of the 9th Supervisory Board of Kangmei Pharmaceutical in 2024
Announcement of Resolutions of the Fourth Interim Meeting of the 9th Board of Directors of Kangmei Pharmaceutical in 2024
Announcement of Resolutions of the Third Interim Meeting of the 9th Board of Supervisors of Kangmei Pharmaceutical in 2024
Kangmei Pharmaceutical\'s announcement on holding the 2024 semi-annual results briefing
Announcement from Kangmei Pharmaceutical regarding the expected increase in routine related party transactions for the year 2024.
Kangmei Pharmaceutical's Ninth Board of Directors' Sixth Meeting Resolution Announcement
Announcement of the resolution of the sixth meeting of the ninth Board of Supervisors of Kangmei Pharmaceuticals
Announcement of the resolution of the 3rd interim meeting of the 9th board of directors of Kangmei Pharmaceutical Co., Ltd. for the year 2024.
Tianzhi International Accounting Firm (Special General Partnership) Special Instructions on Matters Related to the 2023 Annual Report Supervision Work Letter of Kangmei Pharmaceutical Co., Ltd.
Kangmei Pharmaceutical's announcement on holding a performance briefing for the first quarter of 2023 and 2024
Announcement of Resolutions of the Second Interim Meeting of the 9th Board of Directors of Kangmei Pharmaceutical in 2024
Announcement of Resolutions of the Second Interim Meeting of the 9th Board of Supervisors of Kangmei Pharmaceutical in 2024
Tianji International Accounting Firm (Special General Partnership) on Kangmei Pharmaceutical Audit Report (2023)
Kangmei Pharmaceutical's 2023 Independent Director Debriefing Report (Luo Tao)
Announcement of Resolutions of the Fifth Meeting of the 9th Board of Directors of Kangmei Pharmaceutical
Kangmei Pharmaceutical Co., Ltd. Independent Director System (April 2024)
No Data
